Published in Medical Letter on the CDC and FDA, March 2nd, 1998
The committee will approve the official draft of this recommendation after the rotavirus vaccine is licensed for use by the FDA. Rotavirus gastroenteritis is the most common cause of severe and sometimes fatal diarrhea in children.
The vaccine is intended to be given in three oral doses at 2, 4 and 6 months of age and is compatible with other routine childhood immunizations. It was developed through a Cooperative Research and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.